Chitooligosaccharide guanidine inhibits high glucose-induced activation of DAG/PKC pathway by regulating expression of GLUT2 in type 2 diabetic nephropathy rats
Chitooligosaccharide guanidine inhibits high glucose-induced activation of DAG/PKC pathway by regulating expression of GLUT2 in type 2 diabetic nephropathy rats
复制标题
壳寡糖胍通过调节2型糖尿病肾病大鼠GLUT2表达抑制高糖诱导的DAG/PKC通路激活
DOI:
10.1016/j.jff.2017.12.032
复制
发表时间:
2018-02
影响因子:
5.6
通讯作者:
Liu Xiaofei
中科院分区:
文献类型:
--
作者:
Zhang Hai;Zhang Shengsheng;Wang Li;Liu Xiaofei
Previous results from our laboratory showed that chitosan biguanidine hydrochloride (CSGH) and chitooligosaccharide guanidine (COSG) could control glucose uptake by regulating the expression of glucose transporters (GLUTs) in vitro experiments. In this study, we try to delineate changes observed in activation of diacylglycerol (DAG)/protein kinase C-β(PKC-β) pathway and GLUT2 in kidney. STZ-induced diabetic rats were administered COSG via daily intra-gastric gavage for 8 weeks. Obviously, COSG significantly attenuated fasting blood glucose and blood glucose level by modulating the over-expression of GLUT2 and the level of DAG as well. Immunohistological examination revealed that factors such as PKC-βand transforming growth factor-β(TGF-β) diminished to various extents after treatment with COSG, which impinged on the synthesis of extracellular matrix (ECM) components like fibronectin (FN). As a result, high glucose-induced activation of DAG/PKC pathway is inhibited, which is associated with the concentration of glucose controlled by the expression of GLUT2 with the treatment of COSG.
登录
查看更多内容
影响因子:
3.9
作者:
Wang Li;Liu Zongbao;Liu Xiaofei;Wu Yuntang
通讯作者:
Wu Yuntang
影响因子:
3.9
作者:
Ningning Xu;Derun Ding
通讯作者:
Ningning Xu;Derun Ding
影响因子:
4.8
作者:
Venkatesan J;Pangestuti R;Qian ZJ;Ryu B;Kim SK
通讯作者:
Kim SK
影响因子:
--
作者:
Coca SG;Ismail-Beigi F;Haq N;Krumholz HM;Parikh CR
通讯作者:
Parikh CR
影响因子:
7.7
作者:
K. Sharma;F. Ziyadeh
通讯作者:
K. Sharma;F. Ziyadeh